A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer. - Knutson KL; Abu-Fares H; Keating P; Block MS; Norton N; Erskine CL; Cogen D; Assad H; Graff SL; Hamilton EP; Han HS; McIntyre KJ; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)